Tower Research Capital LLC (Trc) Arcturus Therapeutics Holdings Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 307 shares of ARCT stock, worth $3,555. This represents 0.0% of its overall portfolio holdings.
Number of Shares
307
Previous 3,850
92.03%
Holding current value
$3,555
Previous $89,000
94.38%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ARCT
# of Institutions
167Shares Held
25.9MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$54.4 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$30.7 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$23.9 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$23.9 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$22.4 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $308M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...